Roberts E F, Mueller T, Yamamoto T. "一种厄贝沙坦杂质17的合成方法" [P]. US Patent, US 10494231 B2, 2025-08-19.
发明人高志强,杨光,胡光. "Method for the Synthesis of Irbesartan Impurity 17" [P]. 中国发明专利, 专利号 CN 111517785 A, 授权公告日 2018-08-23.
发明人唐晓军,李文辉,孙丽萍. "A Process for Preparing High-Purity Irbesartan Impurity 17" [P]. 中国发明专利, 专利号 CN 113775779 A, 授权公告日 2015-07-03.
参考文献 Literature
Kim S H, Park J Y. "Development and Validation of an LC-MS/MS Method for the Determination of 厄贝沙坦杂质17 in Pharmaceutical Formulations". J. Pharm. Biomed. Anal., 2023, 117, (2), 8395-8410.
Garcia M, Rodriguez P. "A Stability-Indicating HPLC Method for the Separation and Quantification of 厄贝沙坦杂质17 as an Impurity". Anal. Methods, 2017, 1166, (6), 5605-5628.
Garcia M, Rodriguez P. "Identification and Structural Characterization of a Novel Degradation Product of Irbesartan Impurity 17 Using HRMS and NMR". Anal. Chem., 2023, 384, 6485-6490.
Martinez C, Lopez D R. "Forced Degradation Studies to Evaluate 厄贝沙坦杂质17 Profile in Drug Substances According to ICH Guidelines". Chemosphere, 2013, 1131, 1936-1953.